New concepts in paraneoplastic neurological syndromes

Revue Neurologique

Volumn 167, Issue 10, 2011, Pages 729-736

  Honnorat, J ^a,b,c   Viaccoz, A ^a,b,c  

^a HÔPITAL NEUROLOGIQUE   (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Autoantibodies; Cancer; Immunomodulatory therapy; Paraneoplastic neurological syndrome; Synaptic receptors

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; MEMBRANE RECEPTOR; RITUXIMAB;

ARTICLE; CANCER DIAGNOSIS; CELL DEATH; CELLULAR IMMUNITY; DIAGNOSTIC PROCEDURE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; MEMBRANE CHANNEL; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROTEIN TARGETING;

AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; IMMUNOLOGIC FACTORS; PARANEOPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

EID: 81955162922     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.08.001     Document Type: Article

References (33)

1. M.L. Albert, J.C. Darnell, A. Bender, L.M. Francisco, N. Bhardwaj, and R.B. Darnell Tumor-specific killer cells in paraneoplastic cerebellar degeneration Nat Med 4 1998 1321 1324 (Pubitemid 28512116)
2. L. Bataller, D.F. Wade, F. Graus, H.D. Stacey, M.R. Rosenfeld, and J. Dalmau Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer Neurology 62 2004 778 782 (Pubitemid 38298956)
3. J.P. Camdessanche, G. Jousserand, K. Ferraud, C. Vial, P. Petiot, and J. Honnorat The pattern and diagnostic criteria of sensory neuronopathy: a case-control study Brain 132 2009 1723 1733
4. J.P. Camdessanche, N. Streichenberger, G. Cavillon, V. Rogemond, G. Jousserand, and J. Honnorat Brain immunohistopathological study in a patient with anti-NMDAR encephalitis Eur J Neurol 18 2011 929 931
5. J. Dalmau, and M.R. Rosenfeld Paraneoplastic syndromes of the CNS Lancet Neurol 7 2008 327 340 (Pubitemid 351380534)
6. J. Dalmau, F. Graus, A. Villarejo, J.B. Posner, D. Blumenthal, and B. Thiessen Clinical analysis of anti-Ma2-associated encephalitis Brain 127 2004 1831 1844 (Pubitemid 39061559)
7. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M.R. Rosenfeld, and R. Balice-Gordon Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 10 2011 63 74
8. R.B. Darnell, and J.B. Posner Paraneoplastic syndromes involving the nervous system N Engl J Med 349 2003 1543 1554 (Pubitemid 37255041)
9. A. Didelot, and J. Honnorat Update on paraneoplastic neurological syndromes Curr Opin Oncol 21 2009 566 572
10. M. Esposito, P. Penza, G. Orefice, A. Pagano, E. Parente, and A. Abbadessa Successful treatment of paraneoplastic cerebellar degeneration with Rituximab J Neurooncol 86 2008 363 364
11. C. Geis, A. Weishaupt, S. Hallermann, B. Grunewald, C. Wessig, and T. Wultsch Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition Brain 133 2010 3166 3180
12. B. Giometto, W. Grisold, R. Vitaliani, F. Graus, J. Honnorat, and G. Bertolini Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers Arch Neurol 67 2010 330 335
13. F. Graus, F. Keime-Guibert, R. Rene, B. Benyahia, T. Ribalta, and C. Ascaso Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients Brain 124 2001 1138 1148 (Pubitemid 32510382)
14. F. Graus, A. Saiz, and J. Dalmau Antibodies and neuronal autoimmune disorders of the CNS J Neurol 257 2010 509 517
15. J. Honnorat, S. Cartalat-Carel, D. Ricard, J.P. Camdessanche, A.F. Carpentier, and V. Rogemond Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies J Neurol Neurosurg Psychiatry 80 2009 412 416
16. E.G. Hughes, X. Peng, A.J. Gleichman, M. Lai, L. Zhou, and R. Tsou Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis J Neuroscience: 30 2010 5866 5875
17. F. Keime-Guibert, F. Graus, A. Fleury, R. Rene, J. Honnorat, and P. Broet Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone J Neurol Neurosurg Psychiatry 68 2000 479 482 (Pubitemid 30248748)
18. M. Lai, E.G. Hughes, X. Peng, L. Zhou, A.J. Gleichman, and H. Shu AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location Ann Neurol 65 2009 424 434
19. E. Lancaster, M. Lai, X. Peng, E. Hughes, R. Constantinescu, and J. Raizer Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen Lancet Neurol 9 2010 67 76
20. B. Lang, P.C. Molenaar, J. Newsom-Davis, and A. Vincent Passive transfer of Lambert-Eaton myasthenic syndrome in mice: decreased rates of resting and evoked release of acetylcholine from skeletal muscle J Neurochem 42 1984 658 662 (Pubitemid 14198947)
21. M.U. Manto, M.A. Laute, M. Aguera, V. Rogemond, M. Pandolfo, and J. Honnorat Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases Ann Neurol 61 2007 544 551 (Pubitemid 47068136)
22. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction Orphanet J Rare Dis 5 2010 31
23. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies J Neurol. 258 2011 27 33
24. R.M. Mathew, R. Vandenberghe, A. Garcia-Merino, T. Yamamoto, J.C. Landolfi, and M.R. Rosenfeld Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis Neurology 68 2007 900 905 (Pubitemid 46568501)
25. T. Ritzenthaler, J.M. Verret, and J. Honnorat Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors Rev Neurol (Paris) 166 2010 90 95
26. S. Shams'ili, J. de Beukelaar, J.W. Gratama, H. Hooijkaas, M. van den Bent, and M. van't Veer An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes J Neurol 253 2006 16 20 (Pubitemid 43157382)
27. P.A. Sillevis Smitt, G.T. Manley, and J.B. Posner Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice Neurology 45 1995 1873 1878 (Pubitemid 27122961)
28. P. Sillevis Smitt, A. Kinoshita, B. De Leeuw, W. Moll, M. Coesmans, and D. Jaarsma Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor N Engl J Med 342 2000 21 27 (Pubitemid 30020656)
29. M. Tanaka, K. Tanaka, O. Onodera, and S. Tsuji Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss Clin Neurol Neurosurg 97 1995 95 100
30. J. Thone, A. Hohaus, S. Lamprecht, A. Bickel, and F. Erbguth Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration J Neurol Sci 272 2008 171 173
31. M. Tschernatsch, O. Gross, N. Kneifel, M. Kaps, and F. Blaes SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes Autoimmun Rev 8 2009 549 551
32. A. Vincent, and S.R. Irani Caspr2 antibodies in patients with thymomas J Thorac Oncol 5 2010 S277 S280
33. S. Younes-Mhenni, M.F. Janier, L. Cinotti, J.C. Antoine, F. Tronc, and V. Cottin FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes Brain 127 2004 2331 2338 (Pubitemid 39382241)